Special Drug Use-results Survey for Lon… | Clinical Trial

Key information

Conditions

Microscopic Polyangiitis (MPA) Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Autoimmune Diseases Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebral Small Vessel Diseases Cerebrovascular Disorders Granulomatosis With Polyangiitis (GPA) Granulomatosis with Polyangiitis Immune System Diseases Lung Diseases Lung Diseases, Interstitial Microscopic Polyangiitis Nervous System Diseases Respiratory Tract Diseases Skin Diseases Skin Diseases, Vascular Skin and Connective Tissue Diseases Systemic Vasculitis Vascular Diseases Vasculitis

Sex eligibility

All sexes

Study type

Observational

Primary location

Research site

Multiple Locations, Japan

Location status: Recruiting

Location contact

Kazunori Abe, director

CONTACT

[email protected]

0356843575

About this study

The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan

Treatment and study plan

Avacopan

Drug

oral administration

Primary outcomes

Adverse events

Time frame: 2 years

Study contacts

Contact information is provided by the study sponsor or research team.

Kazunori Abe, director

CONTACT

[email protected]

0356843575

Sponsors and collaborators

Lead sponsor

Kissei Pharmaceutical Co., Ltd.

Industry

Registry information

Official study title

Special Drug Use-results Survey for Long-term Use

Important dates

Study start: 2022
Primary completion: 2028
Study completion: 2028
First posted: Jan 3, 2025
Registry last updated: Jan 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting